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A consortium of 25 leading
European scientists in epigenetic
research last month signed a
contract with the European
Commission to establish the
Epigenome Network of
Excellence. The network kicked
off with a meeting at Brno, Czech
Republic, the town made famous
by the abbot and geneticist
Gregor Mendel. This initiative has
been coordinated by Thomas
Jenuwein at the Institute of
Molecular Pathology in Vienna,
together with colleagues in Paris.
The project will receive 12.5
million euros from the EU’s Sixth
Framework programme over the
next five years.
Epigenetic research questions
the traditional view that the DNA
sequence is the exclusive source
of heritable information.
Epigenetic changes are
independent of the genetic code,
but nevertheless can be passed
on to offspring. “There may even
be an epigenetic code that can
determine patterns of gene
expression over many cell
generations,” says Jenuwein.
The new network will create a
virtual institute with three central
activities: a joint research
programme to advance insights
into epigenetic mechanisms; an
initiative to integrate 22 of
Europe’s most promising newly
established teams (NET) in
epigenetic research and the
establishment of an interactive
website that will allow transfer of
up-to-date knowledge in the field
of epigenetics to the scientific
community and the general
public.
The support of newly
established teams forms a key
part of the new network. More
than 25 per cent of the project
funds will go towards support for
these groups over three years.
Young scientists frequently face
problems securing funds in
competition with more
established teams, says
Jenuwein. “With the NET
programme we reversed this
system, established teams will
make funds available for the most
outstanding young colleagues in
Europe,” he says. 
For decades DNA was
considered the exclusive source
of inherited information, but
recent advances in epigenetic
research have changed the way
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The launch of a new research network in Europe bolsters the
continent’s commitment to epigenetic research which kicked off last
year. Nigel Williams reports.
DNA plus: Researchers are studying mechanisms of epigenetics that may be important in controlling a cell’s fate. Shown here are
human pancreatic cells. (Picture: Science Photo Library.)
scientists think about heredity.
Epigenetic mechanisms provide a
memory for cells to remember
their gene expression pattern and
therefore their identity. When this
cellular memory fails it can lead to
perturbed development or
disease. The implications of
epigenetic research for human
biology and health, including
stem cells, cancer and ageing,
are far reaching and may be of
major importance in the post-
genomic era.
The new network bolsters the
Human Epigenome Project which
won financial backing late last
year. The project is a
public/private collaboration that
aims to identify and catalogue
methylation variable positions
(MVPs) in the human genome. As a
prelude, researchers in the
consortium recently completed a
pilot study of the methylation
patterns within the major
histocompatibility complex (MHC)
— a region of chromosome six
associated with more diseases
than any other region in the human
genome — funded by the EU. 
They have identified MVPs in
the vicinity of the promoter and
other relevant regions of
approximately 150 loci within the
MHC in tissues from a range of
individuals. This will provide an
insight into the complex
relationship between genetics
and epigenetics that underlies
both normal and cellular
homeostasis and disease states,
in particular autoimmune
diseases. For the pilot project the
team developed an integrated
genomics-based technology
platform.
The key company involved is
Epigenomics, a transatlantic
biotechnology company with
headquarters in Berlin. 
Amanda Fisher at the British
Medical Research Council’s
Clinical Sciences Centre in
London and Wendy Bickmore at
the Human Genetics Unit in
Edinburgh are leading the public
science activities associated with
the epigenetics project. “This
exciting collaboration will help us
understand how, despite having
the same DNA, cells receive their
different instructions to fulfil their
own unique jobs,” says Fisher.
London, trying to reinvent itself to
come up with a winning bid for
the 2012 Olympic Games, is also
rethinking its role in higher
education and research and the
possibility of greater
collaboration to strengthen the
city’s standing. One recent
statistic stands out: London
attracts more than 65,000
international students each year
— more than any other city.
Historically, London’s
universities have been so busy
competing with one another that
they do not give a second
thought to the possibility of
collaborations. That’s the
conventional wisdom. But a
number of new initiatives
demonstrate a growing collective
spirit in the British capital’s
powerful higher education sector.
Universities and colleges in
London employ more than 58,000
academic and non-academic staff
— about 20 per cent of the
country’s total. The 42
universities and colleges win
more than £600 million in
research funding each year — a
quarter of the national total. And
more than half of these
institutions are involved in
biomedical research.
The capital’s institutions range
from specialists, such as the Trinity
College of Music and Wimbledon
School of Art, to the world-class
multidisciplinary institutions such
as Imperial College London and
University College London. There
is fierce competition for the best
students, academics and research
grants, and many see their rivals as
the best institutions in Europe and
the US, not just Oxford and
Cambridge.
Among those backing
partnership is Adrian Smith,
principal of Queen Mary,
University of London, who is
chairman of London Higher, the
umbrella group that promotes
higher education in the capital.
The group now includes all 42
eligible universities and colleges
and is the largest regional higher
education association in the UK.
Smith argues that universities in
the capital face common
problems that can be tackled by
working together.
International student
recruitment is one example —
London Higher’s research has
found that very few potential
students know any British
universities other than Oxford and
Cambridge. Smith said that
collectively promoting London as
a destination was more rewarding
than individual institutions trying
to sign up students themselves.
“In some sense, London has been
backward in parading its wares
and making the positive case
that’s there. Part of what London
Higher is about is getting the data
together,” he says.
The StudyLondon campaign
and website is an example of the
benefits of collaboration. The
website is a virtual shop window
for higher education in London,
offering potential students
everything from visa application
forms to guides to the best pubs
and clubs.
In addition, institutions have set
up a number of partnerships that
have benefits for students and
academics. They include the joint
facility of health and social care
sciences created by Kingston
University and St George’s
Hospital Medical School. Then
there is the strategic alliance in
the health sciences between
Queen Mary and City University.
Smith says there was a “stacked
up queue” of initiatives waiting to
be implemented.
The London Development
Agency, set up four years ago as
the last of the nine regional bodies
charged with driving economic
growth and competitiveness, is
responsible for nurturing some of
the projects.
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New studies recommend that
greater collaboration between
the city’s higher education
institutions could help it achieve
the status of one of the global
learning capitals. Biomedicine
and science history should win
out too. Nigel Williams reports.
London’s global bid
